A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development - Top-Institutions - MDSpire

Exploring Patient Insights and Preferences in Lupus Care to Inform the Development of Treatment Guidelines

  • By

  • Shivani Garg

  • Izzy Hartel

  • Lisa R. Sammaritano

  • Anca Askanase

  • Bonnie L. Bermas

  • Maria Dall'Era

  • Alí Duarte-García

  • Victoria P. Werth

  • Brad Rovin

  • Reem A. Mustafa

  • Amy S. Turner

  • Bené Williams

  • Brian L. Ung

  • Hiya Bhavsar

  • Monique C. Gore-Massy

  • Nahirannette Pulido

  • Natacha Guerrero

  • Natalie M. Smith

  • Wambui Machua

  • Linda T. Hiraki

  • Mary Beth Son

  • July 1, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    American College of Rheumatology
    American College of Rheumatology

    Atlanta, Georgia

    Key Differentiators

    • Rheumatology

  • #2

    Lupus Foundation of America
    Lupus Foundation of America

    Washington, D.C.

    Key Differentiators

    • Rheumatology

  • #3

    European League Against Rheumatism
    European League Against Rheumatism

    Brussels, Belgium

    Key Differentiators

    • Rheumatology

  • #4

    St Antoine Hospital
    St Antoine Hospital

    Paris, France

    Key Differentiators

    • Rheumatology

  • #5

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Rheumatology

Original Source(s)

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

  • by Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte-García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore-Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son

  • July 1, 2026

Related Content

How Epstein Barr virus shapes lupus autoimmunity: mechanistic insights and therapeutic perspectives

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Case Report: Overlapping multiple sclerosis and neuropsychiatric systemic lupus erythematosus with positive MOG-IgG: a case initially misdiagnosed as depression